Logo image of TOM2.AS

TOMTOM NV (TOM2.AS) Stock Fundamental Analysis

AMS:TOM2 - Euronext Amsterdam - NL0013332471 - Common Stock - Currency: EUR

4.696  -0.17 (-3.57%)

Fundamental Rating

2

Taking everything into account, TOM2 scores 2 out of 10 in our fundamental rating. TOM2 was compared to 101 industry peers in the Software industry. TOM2 has a bad profitability rating. Also its financial health evaluation is rather negative. TOM2 has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

TOM2 had negative earnings in the past year.
In the past year TOM2 had a positive cash flow from operations.
In the past 5 years TOM2 always reported negative net income.
In multiple years TOM2 reported negative operating cash flow during the last 5 years.
TOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFTOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

With a Return On Assets value of -2.39%, TOM2 perfoms like the industry average, outperforming 41.41% of the companies in the same industry.
With a Return On Equity value of -12.45%, TOM2 is not doing good in the industry: 64.65% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.39%
ROE -12.45%
ROIC N/A
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
TOM2.AS Yearly ROA, ROE, ROICTOM2.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

Looking at the Gross Margin, with a value of 84.87%, TOM2 belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
TOM2's Gross Margin has improved in the last couple of years.
TOM2 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
TOM2.AS Yearly Profit, Operating, Gross MarginsTOM2.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

3

2. Health

2.1 Basic Checks

TOM2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TOM2 has been reduced compared to 1 year ago.
Compared to 5 years ago, TOM2 has less shares outstanding
Compared to 1 year ago, TOM2 has a worse debt to assets ratio.
TOM2.AS Yearly Shares OutstandingTOM2.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOM2.AS Yearly Total Debt VS Total AssetsTOM2.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

TOM2 has an Altman-Z score of 1.21. This is a bad value and indicates that TOM2 is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.21, TOM2 is not doing good in the industry: 67.68% of the companies in the same industry are doing better.
TOM2 has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.25, TOM2 is in line with its industry, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 1.21
ROIC/WACCN/A
WACC7.28%
TOM2.AS Yearly LT Debt VS Equity VS FCFTOM2.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

TOM2 has a Current Ratio of 1.75. This is a normal value and indicates that TOM2 is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.75, TOM2 is doing good in the industry, outperforming 68.69% of the companies in the same industry.
A Quick Ratio of 1.70 indicates that TOM2 should not have too much problems paying its short term obligations.
TOM2 has a better Quick ratio (1.70) than 70.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.7
TOM2.AS Yearly Current Assets VS Current LiabilitesTOM2.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

TOM2 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.25%, which is quite good.
The Revenue has decreased by -1.77% in the past year.
The Revenue has been decreasing by -3.90% on average over the past years.
EPS 1Y (TTM)14.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.46%
Revenue 1Y (TTM)-1.77%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%-0.8%

3.2 Future

Based on estimates for the next years, TOM2 will show a very strong growth in Earnings Per Share. The EPS will grow by 76.90% on average per year.
TOM2 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.40% yearly.
EPS Next Y59.82%
EPS Next 2Y96.17%
EPS Next 3Y76.9%
EPS Next 5YN/A
Revenue Next Year-0.09%
Revenue Next 2Y3.49%
Revenue Next 3Y4.46%
Revenue Next 5Y7.4%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TOM2.AS Yearly Revenue VS EstimatesTOM2.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
TOM2.AS Yearly EPS VS EstimatesTOM2.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TOM2. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TOM2. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TOM2.AS Price Earnings VS Forward Price EarningsTOM2.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TOM2 is valued a bit cheaper than 76.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.43
TOM2.AS Per share dataTOM2.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as TOM2's earnings are expected to grow with 76.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y96.17%
EPS Next 3Y76.9%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TOM2!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TOMTOM NV

AMS:TOM2 (3/7/2025, 7:00:00 PM)

4.696

-0.17 (-3.57%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)04-15 2025-04-15
Inst Owners22.75%
Inst Owner ChangeN/A
Ins Owners53.12%
Ins Owner ChangeN/A
Market Cap587.00M
Analysts45
Price Target5.53 (17.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend5.75
Dividend Growth(5Y)374.11%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.52%
Min Revenue beat(2)-1.1%
Max Revenue beat(2)4.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-8.99%
Max Revenue beat(4)4.14%
Revenue beat(8)4
Avg Revenue beat(8)1.5%
Revenue beat(12)6
Avg Revenue beat(12)2.19%
Revenue beat(16)6
Avg Revenue beat(16)0.48%
PT rev (1m)-15.56%
PT rev (3m)-26.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-141.67%
EPS NY rev (3m)-127.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.25%
Revenue NY rev (3m)-5.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.02
P/FCF N/A
P/OCF 434.17
P/B 4.23
P/tB N/A
EV/EBITDA 10.43
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.01
OCFY0.23%
SpS4.6
BVpS1.11
TBVpS-0.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.39%
ROE -12.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.87%
FCFM N/A
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
F-Score8
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA 2.26
Cap/Depr 15.68%
Cap/Sales 0.97%
Interest Coverage N/A
Cash Conversion 8.86%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.7
Altman-Z 1.21
F-Score8
WACC7.28%
ROIC/WACCN/A
Cap/Depr(3y)20.27%
Cap/Depr(5y)16.21%
Cap/Sales(3y)1.63%
Cap/Sales(5y)1.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.46%
EPS Next Y59.82%
EPS Next 2Y96.17%
EPS Next 3Y76.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.77%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%-0.8%
Revenue Next Year-0.09%
Revenue Next 2Y3.49%
Revenue Next 3Y4.46%
Revenue Next 5Y7.4%
EBIT growth 1Y-15.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year350.52%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-120.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.86%
OCF growth 3Y-66.75%
OCF growth 5Y-57.16%